{"entity":{"id":"mpm-bioimpact","kind":"company","name":"MPM BioImpact","aka":[],"tldr":"A Boston biotech investor, formerly MPM Capital, that builds and funds companies and runs an Oncology Impact Fund that donates part of its profits to cancer research. It built Aktis Oncology and backs Cullinan Oncology and Tizona.","summary":"MPM BioImpact (formerly MPM Capital) is based at 399 Boylston Street, Boston, and claims '30+ Years of Biotech Investing', '60 FDA-approved drugs' and '120+ M&A and IPO events' on its homepage. Its portfolio page says its 'current strategy that focuses on company building began in 2010'; it invests in private and public companies and its trademarks include the Oncology Impact Fund (OIF), which pairs oncology venture investing with philanthropic donations. The homepage says 'We built Aktis Oncology to realize the transformative potential of alpha radio-pharmaceuticals', describing miniprotein actinium conjugates for solid tumours, and 'We built Orna Therapeutics' (circular RNA, acquired by Lilly in 2026). The portfolio page lists Aktis, Cullinan Oncology, Tizona Therapeutics, Frontier Medicines and Umoja Biopharma among others; the news page carries Aktis first-in-human dosimetry data and J&J's acquisition of Firefly Bio.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://mpmbioimpact.com/"},{"label":"Portfolio","url":"https://mpmbioimpact.com/portfolio/"},{"label":"News","url":"https://mpmbioimpact.com/news/"}],"tags":["vc"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["aktis-oncology","firefly-bio","frontier-medicines","umoja-biopharma"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Founding year of MPM Capital not stated on fetched pages; omitted. Aktis, Frontier Medicines, Umoja and Orna are already in the graph."],"hq":"Boston, MA","country":"US","companyType":"investor","website":"https://mpmbioimpact.com/","investors":[],"funding":[]},"route":"/companies/mpm-bioimpact/","neighbours":{"company":[{"id":"aktis-oncology","kind":"company","name":"Aktis Oncology","route":"/companies/aktis-oncology/"},{"id":"firefly-bio","kind":"company","name":"Firefly Bio","route":"/companies/firefly-bio/"},{"id":"frontier-medicines","kind":"company","name":"Frontier Medicines","route":"/companies/frontier-medicines/"},{"id":"photys-therapeutics","kind":"company","name":"Photys Therapeutics","route":"/companies/photys-therapeutics/"},{"id":"umoja-biopharma","kind":"company","name":"Umoja Biopharma","route":"/companies/umoja-biopharma/"}]}}